In today’s recent session, 0.8 million shares of the Viking Therapeutics Inc (NASDAQ:VKTX) have been traded, and its beta is 0.71. Most recently the company’s share price was $28.17, and it changed around -$1.32 or -4.48% from the last close, which brings the market valuation of the company to $3.16B. VKTX at last check was trading at a discount to its 52-week high of $81.86, offering almost -190.59% off that amount. The share price’s 52-week low was $18.92, which indicates that the recent value has risen by an impressive 32.84% since then.
Viking Therapeutics Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.21. If we narrow it down even further, the data shows that 0 out of 19 analysts rate the stock as a Sell; another 7 rate it as Overweight. Among the rest, 2 recommended VKTX as a Hold, whereas 10 deemed it a Buy, and 0 rated it as Underweight. Viking Therapeutics Inc is expected to report earnings per share of -0.44 for the current quarter.
Viking Therapeutics Inc (NASDAQ:VKTX) trade information
Instantly VKTX has been showing red trend so far today with a performance of -4.48% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 30.28 on recent trading dayincreased the stock’s daily price by 6.97%. The company’s shares are currently down -30.00% year-to-date, but still up 0.82% over the last five days. On the other hand, Viking Therapeutics Inc (NASDAQ:VKTX) is 24.54% up in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $74.5, which translates to bulls needing to increase their stock price by 62.19% from its current value. Analyst projections state that VKTX is forecast to be at a low of $74 and a high of $75.
Forecasts for the next quarter put sales growth at 0.00%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -23.00%.
VKTX Dividends
Viking Therapeutics Inc’s next quarterly earnings report is expected to be released in June.
VANGUARD GROUP INC, with 9.147% or 10.1 million shares worth $535.26 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund were the top two Mutual Funds as of Dec 31, 2024 . The former held 3.3 shares worth $93.41 million, making up 2.94% of all outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund held roughly 2.7 shares worth around $76.26 million, which represents about 2.40% of the total shares outstanding.
